These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 21683340
1. Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. de Moraes M, de Lucena HF, de Azevedo PR, Queiroz LM, Costa Ade L. Arch Oral Biol; 2011 Nov; 56(11):1256-63. PubMed ID: 21683340 [Abstract] [Full Text] [Related]
4. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. Andrade FR, Sousa DP, Mendonça EF, Silva TA, Lara VS, Batista AC. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Oct; 106(4):548-55. PubMed ID: 18928898 [Abstract] [Full Text] [Related]
5. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Menezes R, Bramante CM, da Silva Paiva KB, Letra A, Carneiro E, Fernando Zambuzzi W, Granjeiro JM. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):404-9. PubMed ID: 16920551 [Abstract] [Full Text] [Related]
7. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. Tekkesin MS, Mutlu S, Olgac V. Head Neck Pathol; 2011 Sep; 5(3):248-53. PubMed ID: 21643971 [Abstract] [Full Text] [Related]
12. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732 [Abstract] [Full Text] [Related]
13. Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. Nonaka CF, Cavalcante RB, Nogueira RL, de Souza LB, Pinto LP. Arch Oral Biol; 2012 Mar; 57(3):230-7. PubMed ID: 21871606 [Abstract] [Full Text] [Related]
14. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma. Chuang FH, Hsue SS, Wu CW, Chen YK. J Oral Pathol Med; 2009 Nov; 38(10):753-8. PubMed ID: 19566744 [Abstract] [Full Text] [Related]
16. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [Abstract] [Full Text] [Related]
17. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D. Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801 [Abstract] [Full Text] [Related]
19. Expression of RANKL and OPG in middle ear cholesteatoma tissue. Jeong JH, Park CW, Tae K, Lee SH, Shin DH, Kim KR, Park YW. Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057 [Abstract] [Full Text] [Related]
20. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells. Fan R, Sun B, Zhang CF, Lü YL, Xuan W, Wang QQ, Yin XZ. Chin Med J (Engl); 2011 Jul; 124(14):2162-6. PubMed ID: 21933620 [Abstract] [Full Text] [Related] Page: [Next] [New Search]